Center-Authored Papers

Filters: Author is Gopal, Ajay  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
I
Graf S, Gopal A.  2016.  Idelalisib for the treatment of non-Hodgkin lymphoma.. Expert opinion on pharmacotherapy. :1-10. Abstract
P
Reddy P, Kanan S, Cowan A, Warren H, Till B, Shadman M, Cassaday R, Press O, Shustov A, Gopal A et al..  2017.  Pegylated GCSF Can Be Used With First-Line da-EPOCH-R Without Compromising Dose Intensity, Safety, or Efficacy.. Clinical lymphoma, myeloma & leukemia. Abstract
Richter M, Yumul R, Saydaminova K, Wang H, Gough M, Baldessari A, Cattaneo R, Lee F, Wang C-HK, Jang H et al..  2016.  Preclinical safety, pharmacokinetics, pharmacodynamics, and biodistribution studies with Ad35K++ protein: a novel rituximab cotherapeutic.. Molecular therapy. Methods & clinical development. 5:16013. Abstract
Green DJ, Pagel JM, Pantelias A, Hedin N, Lin Y, Wilbur SD, Gopal A, Hamlin DK, Press OW.  2007.  Pretargeted radioimmunotherapy for B-cell lymphomas.. Clinical cancer research : an official journal of the American Association for Cancer Research. 13(18 Pt 2):5598s-5603s. Abstract
R
Bartlett NL, Chen R, Fanale MA, Brice P, Gopal A, Smith SE, Advani R, Matous JV, Ramchandren R, Rosenblatt JD et al..  2014.  Retreatment with brentuximab vedotin in patients with CD30-positive hematologic malignancies.. Journal of hematology & oncology. 7(1):24. Abstract